173 related articles for article (PubMed ID: 12653948)
1. Pathological significance of oxidative cellular damage in human alcoholic liver disease.
Seki S; Kitada T; Sakaguchi H; Nakatani K; Wakasa K
Histopathology; 2003 Apr; 42(4):365-71. PubMed ID: 12653948
[TBL] [Abstract][Full Text] [Related]
2. In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases.
Seki S; Kitada T; Yamada T; Sakaguchi H; Nakatani K; Wakasa K
J Hepatol; 2002 Jul; 37(1):56-62. PubMed ID: 12076862
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological significance of oxidative cellular damage in non-alcoholic fatty liver diseases.
Seki S; Kitada T; Sakaguchi H
Hepatol Res; 2005 Oct; 33(2):132-4. PubMed ID: 16198621
[TBL] [Abstract][Full Text] [Related]
4. Divergent behaviour of oxidative stress markers 8-hydroxydeoxyguanosine (8-OHdG) and 4-hydroxy-2-nonenal (HNE) in breast carcinogenesis.
Karihtala P; Kauppila S; Puistola U; Jukkola-Vuorinen A
Histopathology; 2011 May; 58(6):854-62. PubMed ID: 21585424
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical detection of 4-hydroxy-2-nonenal-modified-protein adducts in human alcoholic liver diseases.
Ohhira M; Ohtake T; Matsumoto A; Saito H; Ikuta K; Fujimoto Y; Ono M; Toyokuni S; Kohgo Y
Alcohol Clin Exp Res; 1998 May; 22(S3 Pt 1):145S-149S. PubMed ID: 9622393
[TBL] [Abstract][Full Text] [Related]
6. In situ detection of oxidative DNA damage, 8-hydroxydeoxyguanosine, in chronic human liver disease.
Kitada T; Seki S; Iwai S; Yamada T; Sakaguchi H; Wakasa K
J Hepatol; 2001 Nov; 35(5):613-8. PubMed ID: 11690707
[TBL] [Abstract][Full Text] [Related]
7. Predictive power of biomarkers of oxidative stress and inflammation in patients with hepatitis C virus-associated hepatocellular carcinoma.
Maki A; Kono H; Gupta M; Asakawa M; Suzuki T; Matsuda M; Fujii H; Rusyn I
Ann Surg Oncol; 2007 Mar; 14(3):1182-90. PubMed ID: 17195915
[TBL] [Abstract][Full Text] [Related]
8. Detection of 1,N2-propanodeoxyguanosine adducts of trans-4-hydroxy-2-nonenal after gavage of trans-4-hydroxy-2-nonenal or induction of lipid peroxidation with carbon tetrachloride in F344 rats.
Wacker M; Wanek P; Eder E
Chem Biol Interact; 2001 Sep; 137(3):269-83. PubMed ID: 11566294
[TBL] [Abstract][Full Text] [Related]
9. Formation of 8-hydroxy-2'-deoxyguanosine and 4-hydroxy-2-nonenal-modified proteins in rat liver after ischemia-reperfusion: distinct localization of the two oxidatively modified products.
Yamagami K; Yamamoto Y; Kume M; Ishikawa Y; Yamaoka Y; Hiai H; Toyokuni S
Antioxid Redox Signal; 2000; 2(1):127-36. PubMed ID: 11232593
[TBL] [Abstract][Full Text] [Related]
10. Carcinogenic Etheno DNA Adducts in Alcoholic Liver Disease: Correlation with Cytochrome P-4502E1 and Fibrosis.
Mueller S; Peccerella T; Qin H; Glassen K; Waldherr R; Flechtenmacher C; Straub BK; Millonig G; Stickel F; Bruckner T; Bartsch H; Seitz HK
Alcohol Clin Exp Res; 2018 Feb; 42(2):252-259. PubMed ID: 29120493
[TBL] [Abstract][Full Text] [Related]
11. Glutathione conjugates of 4-hydroxy-2(E)-nonenal as biomarkers of hepatic oxidative stress-induced lipid peroxidation in rats.
Völkel W; Alvarez-Sánchez R; Weick I; Mally A; Dekant W; Pähler A
Free Radic Biol Med; 2005 Jun; 38(11):1526-36. PubMed ID: 15890627
[TBL] [Abstract][Full Text] [Related]
12. Unaltered brain levels of 1,N2-propanodeoxyguanosine adducts of trans-4-hydroxy-2-nonenal in Alzheimer's disease.
Götz ME; Wacker M; Luckhaus C; Wanek P; Tatschner T; Jellinger K; Leblhuber F; Ransmayr G; Riederer P; Eder E
Neurosci Lett; 2002 May; 324(1):49-52. PubMed ID: 11983292
[TBL] [Abstract][Full Text] [Related]
13. Cytoplasmic fine granular expression of 8-hydroxydeoxyguanosine reflects early mitochondrial oxidative DNA damage in nonalcoholic fatty liver disease.
Nomoto K; Tsuneyama K; Takahashi H; Murai Y; Takano Y
Appl Immunohistochem Mol Morphol; 2008 Jan; 16(1):71-5. PubMed ID: 18091316
[TBL] [Abstract][Full Text] [Related]
14. Decreased antioxidant enzyme expression and increased oxidative damage in erosive lichen planus of the vulva.
Sander CS; Cooper SM; Ali I; Dean D; Thiele JJ; Wojnarowska F
BJOG; 2005 Nov; 112(11):1572-5. PubMed ID: 16225582
[TBL] [Abstract][Full Text] [Related]
15. Cytochromes P450 2A6, 2E1, and 3A and production of protein-aldehyde adducts in the liver of patients with alcoholic and non-alcoholic liver diseases.
Niemelä O; Parkkila S; Juvonen RO; Viitala K; Gelboin HV; Pasanen M
J Hepatol; 2000 Dec; 33(6):893-901. PubMed ID: 11131450
[TBL] [Abstract][Full Text] [Related]
16. Identification of 5' AMP-activated kinase as a target of reactive aldehydes during chronic ingestion of high concentrations of ethanol.
Shearn CT; Backos DS; Orlicky DJ; Smathers-McCullough RL; Petersen DR
J Biol Chem; 2014 May; 289(22):15449-62. PubMed ID: 24722988
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical evaluation of oxidative stress in murine lungs after cigarette smoke exposure.
Aoshiba K; Koinuma M; Yokohori N; Nagai A
Inhal Toxicol; 2003 Sep; 15(10):1029-38. PubMed ID: 12928978
[TBL] [Abstract][Full Text] [Related]
18. Oxidative mechanisms in the pathogenesis of alcoholic liver disease.
Albano E
Mol Aspects Med; 2008; 29(1-2):9-16. PubMed ID: 18045675
[TBL] [Abstract][Full Text] [Related]
19. In situ detection of lipid peroxidation by-products in chronic liver diseases.
Paradis V; Kollinger M; Fabre M; Holstege A; Poynard T; Bedossa P
Hepatology; 1997 Jul; 26(1):135-42. PubMed ID: 9214462
[TBL] [Abstract][Full Text] [Related]
20. Expression of oxidative stress-related molecules in circulating leukocytes and urine in patients with chronic viral hepatitis.
Saeki T; Ichiba M; Tanabe N; Ueki M; Okamoto K; Matsunaga Y; Hosho K; Kanbe T; Tsuchiya H; Kurimasa A; Yamada S; Hirooka Y; Hisatome I; Kishimoto Y; Suou T; Murawaki Y; Kawasaki H; Yodoi J; Shiota G
Liver Int; 2006 Mar; 26(2):157-65. PubMed ID: 16448453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
